Загрузка...
Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19
Novel coronavirus disease 2019 (COVID-19) is known to cause severe pneumonia and acute respiratory distress syndrome which may lead to death. Several treatments have been tested in the race to find a treatment regimen for this deadly viral infection. Tocilizumab, a recombinant humanized anti-interle...
Сохранить в:
Главные авторы: | , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Серии: | Annals of Thoracic Medicine |
Предметы: | |
Online-ссылка: | http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2020;volume=15;issue=3;spage=171;epage=173;aulast=Douedi |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|